Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
CytoDyn, Inc.
CytoDyn, Inc.
Mayo Clinic
Fundación GECP
H. Lee Moffitt Cancer Center and Research Institute
Takeda
Bristol-Myers Squibb
Repare Therapeutics
Massachusetts General Hospital
Gilead Sciences
PharmaMar
Bristol-Myers Squibb
St. Jude Children's Research Hospital
PharmaMar
BeiGene
Incyte Corporation
Incyte Corporation
Amgen
Merck Sharp & Dohme LLC
Columbia University
University of Pennsylvania
Bristol-Myers Squibb
Memorial Sloan Kettering Cancer Center
BeiGene
EMD Serono
CicloMed LLC
Ipsen
Agalimmune Ltd.
Alliance for Clinical Trials in Oncology
BerGenBio ASA
NanoCarrier Co., Ltd.
ImmunoGen, Inc.
Eisai Inc.
Amgen
Bristol-Myers Squibb
ImmuneSensor Therapeutics Inc.
Canadian Cancer Trials Group
Merck KGaA, Darmstadt, Germany
Taiho Pharmaceutical Co., Ltd.
M.D. Anderson Cancer Center
BeiGene
BeiGene
BeiGene
EMD Serono
Boehringer Ingelheim
ImaginAb, Inc.
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd
Memorial Sloan Kettering Cancer Center
Pfizer